Founded in Switzerland in 2011, phamax AG is a research and consulting company, specialising in analytical and scientific market access programmes in the healthcare field. The companies’ clients comprise health authorities, patient and physician associations and pharmacos.
The company’s devoted team is composed of physicians, marketing and sales experts, and data analytics experts from various backgrounds, including non-governmental organisations (NGOs), physician associations, hospital management, pharmacos, and more.
phamax’s geographical focus includes emerging marketplaces, particularly Africa, Eastern Europe, the Middle East, CIS, and APAC, where the firm’s highly competent team have conducted over 100 analytical and scientific projects over the past three years.
Through its research platform – Focus Scientific Research Center (‘FSRC’), the company develops and implements scientific programmes to enhance general awareness of diseases as well as patients’ access to diagnosis, treatment and follow-up care. Through FSRC's activities, phamax has built a wide international network of universities, disease experts, healthcare authorities and patient groups. By leveraging this network, the firm offers actionable and pragmatic solutions to its clients.
Publications found:
8
Sort by:
Healthcare Market Access: Indonesia
US$ 1,999.00
... number of healthcare personnel in the country are also comprehensively covered. Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of ... market of the country. Furthermore, the profiles of major diseases with high burden for the country have been covered. Market Access: ...
December 2014
113 pages
Healthcare Market Access: Vietnam
US$ 1,999.00
... number of healthcare personnel in the country are also comprehensively covered. Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of ... market of the country. Furthermore, the profiles of major diseases with high burden for the country have been covered. Market Access: ...
December 2014
126 pages
Healthcare Market Access: Poland
US$ 199.00
... section. Moreover, healthcare expenditure and major healthcare providers are mentioned. The profiles of major hospitals and the number of healthcare personnel in the ... the pharmaceutical market of the country. Furthermore, major diseases with high burden for the country have been covered. Market Access: This ...
December 2014
25 pages
Healthcare Market Access: Czech Republic
US$ 199.00
... section. Moreover, healthcare expenditure and major healthcare providers are mentioned. The profiles of major hospitals and the number of healthcare personnel in the ... the pharmaceutical market of the country. Furthermore, major diseases with high burden for the country have been covered. Market Access: This ...
December 2014
36 pages
Evolution of Technologies for Therapeutic Antibodies-From mAbs to Biosimilars
US$ 1,999.00
The report provides in-depth information on technologicial platforms being developed for monoclonal antibodies and how they have been improvised for biosimilar development. Also various issues pertaining to manufacturing of biosimilars have been highlighted with possible solutions to to address the hurdles.
December 2014
64 pages
Healthcare Market Access: Egypt
US$ 1,299.00
... Moreover, healthcare expenditure and major healthcare providers are mentioned. The profiles of major hospitals and the number of healthcare personnel in ... : As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, ...
December 2014
79 pages
Healthcare Market Access: Morocco
US$ 1,299.00
... healthcare structure of the country in terms of primary, secondary and tertiary care, and also a general note on the country’s health expenditure. Pharmaceutical Market Access: The sections gives detailed account of various types of health insurance currently operating in Morocco, ...
December 2014
89 pages
Healthcare Market Access: Thailand
US$ 1,999.00
... healthcare personnel in the country are also comprehensively covered. Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in ... As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover ...
December 2014
136 pages
